Form D · Biotechnology
Protagonist Therapeutics, Inc
Milpitas, CA · CIK 0001377121
Offering snapshot reported Jul 24, 2015 · SEC filing
- Reported sold
- $17.5M Offering amount: $40M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 10, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 24, 2015 | Initial | $17,499,999 | No comparison | 9 | SEC filing |
| Jun 11, 2013 | Initial | $7,000,000 | No comparison | 4 | SEC filing |
| Sep 28, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-244411
Source: Form D, filed Jul 24, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Panaccio, Ph.D. | Director |
| Dinesh V. Patel, Ph D | Director, Executive |
| Nicholas Peace | Director |
| Harold Selick | Director |
| Harold E. Selick, Ph.D. | Director |
| Armen Shanafelt | Director |
| Armen Shanafelt, Ph.D. | Director |
| Paul F. Truex | Director |
| Asish K. Xavier | Director |
| Asish K. Xavier, Ph.D. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
521 Cottonwood Drive, Suite 100
Milpitas, CA, 95035-7404
Milpitas, CA, 95035-7404